-
News | 2019.03.21
The issues of epidemiology with Arnaud Fontanet
What is public health? And epidemiology? This discipline is that of Arnaud Fontanet (Institut Pasteur, CNAM) who holds the chair of Public Health at the Collège de France (2018-2019). He explains all the interest of this new chair.Pr. Arnaud Fontanet (Institut Pasteur, CNAM) who holds the chair of Public Health at the Collège de France (2018-2019) explains the major issues of epidemiology. He...
-
Document de presse | 2019.04.15
A new bacteria-killing weapon in the fight against antibiotic resistance
When the first antibiotics were discovered in the early 20th century, the rate of death from infectious diseases fell dramatically. But the emergence of multidrug-resistant bacteria as a result of antibiotic misuse is raising fears that by 2050, these same diseases will once again become the leading cause of death worldwide. In a bid to boost the arsenal available to tackle this threat,...
-
Article | 2019.04.03
Pasteur International Joint Research Unit (PIU)
You are a leader of a team or a unit at Institut Pasteur and you want to create a framework of partnership with international teams on issues of common interest. You can apply for the creation of a Pasteur International joint research Unit (PIU).
-
Article | 2019.04.03
CALL FOR PROPOSALS 2019 Pasteur Joint International Research Unit Partnership within IPIN
To strengthen the partnership with institutes from the Institut Pasteur International Network (IPIN), the Institut Pasteur (IP) will support the creation of two Pasteur International Joint Research Units (PIU/IP-RIIP).
-
News | 2019.02.14
Renewal of the status of the Pasteur International Network Association as a "non-State actor in official relationship" with WHO
The renewal of the status of the International Pasteur Association Network- APIN "as a non-state actor in official relations" with WHO was confirmed by the Executive Board on 31 January 2019 for 3 years in accordance with a 2019-2021 collaboration plan, submitted in autumn 2018.
-
News | 2019.04.03
Discovery of a restriction factor for hepatitis B virus
Hepatitis B is a viral liver infection that can lead to acute or chronic conditions. Although there is a vaccine that offers protection against the virus, current treatments which prevent the virus from replicating are not curative for infected individuals. Scientists at the Institut Pasteur working in collaboration with the CNRS have demonstrated that a cellular protein is capable of acting as a...
-
News | 2019.04.04
The 2019 "Prince Albert II of Monaco - Institut Pasteur" Prize is awarded to Joacim Rocklöv
During the Monaco Ocean Week*, on Thursday 28 March, His Serene Highness, the Sovereign Prince Albert II, in the presence of Professor Stewart Cole, Director General of the Institut Pasteur, awarded the "Prince Albert II of Monaco - Institut Pasteur" prize to Professor Joacim Rocklöv for his research work on climate-related arbovirus epidemics. Since 2012, this prize has been awarded to...
-
Page avancée | 2019.04.04
2018 Thesis and Ceremony
2018 Thesis and Ceremony
-
News | 2019.04.01
Immune cells fighting blood cancer visualized for the first time
When cancer escapes the immune system, our defenses are rendered powerless and are unable to fight against the disease. Chimeric antigen receptor T cells (CAR T cells) represent a promising immunotherapy strategy, developed with the aim of tackling tumors head-on. But the occurrence of relapse in some patients remains a challenge. Scientists at the Institut Pasteur have identified the precise...
-
News | 2019.04.10
Innate immune responses – redefining how innate lymphoid cells develop
The innate immune response represents an important natural process providing a critical line of defense against infection and cancer. Innate lymphoid cells (ILCs) play a key role in this early immune response. Researchers at the Institut Pasteur's Innate Immunity Unit (Inserm U1223) examining how these cells develop have identified new ILC precursors. This discovery constitutes a revolution for...
